KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Deferred Taxes (2016 - 2025)

Thermo Fisher Scientific's Deferred Taxes history spans 17 years, with the latest figure at $89.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 144.06% year-over-year to $89.0 million, compared with a TTM value of -$639.0 million through Dec 2025, up 47.15%, and an annual FY2025 reading of -$639.0 million, up 47.15% over the prior year.
  • Deferred Taxes for Q4 2025 was $89.0 million at Thermo Fisher Scientific, up from -$127.0 million in the prior quarter.
  • The five-year high for Deferred Taxes was $339.0 million in Q2 2022, with the low at -$1.9 billion in Q4 2023.
  • Average Deferred Taxes over 5 years is -$75.3 million, with a median of $147.0 million recorded in 2021.
  • Year-over-year, Deferred Taxes soared 1512.5% in 2022 and then tumbled 1551.88% in 2023.
  • Tracing TMO's Deferred Taxes over 5 years: stood at $192.0 million in 2021, then crashed by 30.73% to $133.0 million in 2022, then tumbled by 1551.88% to -$1.9 billion in 2023, then surged by 89.54% to -$202.0 million in 2024, then surged by 144.06% to $89.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Deferred Taxes are $89.0 million (Q4 2025), -$127.0 million (Q3 2025), and -$880.0 million (Q2 2025).